Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

279
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
279
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

657
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
657
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.3K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.3K
Determination of Renal Drug Clearance: Graphical and Midpoint Methods01:07

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

442
Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
442
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

370
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
370
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

658
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
658

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same author

An Ether-Containing Hafnium-Diethylene Glycol Dry Resist Prepared by Molecular Layer Deposition for Mild-Acid Development.

Nanomaterials (Basel, Switzerland)·2026
Same author

Perturbing glycosylphosphatidylinositol (GPI)-anchor biosynthesis alters cell wall architecture and modulates fungal morphology.

bioRxiv : the preprint server for biology·2026
Same author

Mycoelectronics: Bioprinted living fungal bioelectronics for artificial sensation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

CXCL8 Enhances Malignancy of GBM via TNFα-NFκB Mediated Suppression of Ferroptosis.

Applied biochemistry and biotechnology·2026
Same author

Tuning *OH Oxidativity via a Cu-Co(OH)<sub>2</sub> Cocatalyst on a Hematite Photoanode for Selective Cyclohexanone Oxidation.

Journal of the American Chemical Society·2026

相关实验视频

Updated: Feb 26, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

874

对eGFR斜坡估计和对各种估计方法进行比较分析的估计框架开发.

Tuo Wang1, Yu Du2

  • 1Global Statistical Sciences, Eli Lilly and Company, Indianapolis, Indiana, USA. tuo.wang@lilly.com.

Therapeutic innovation & regulatory science
|February 25, 2026
PubMed
概括
此摘要是机器生成的。

为了改善慢性病 (CKD) 临床试验结果,建议使用标准化框架来估计估计的球透率 (eGFR) 斜率. 这种方法提高了CKD治疗开发的可靠性和可比性.

关键词:
在EGFR的斜坡坡上.估计和估计 估计和估计慢性脏疾病 慢性脏疾病混合效应模型的混合效应模型替代终点是一个替代终点.

更多相关视频

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.7K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K

相关实验视频

Last Updated: Feb 26, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

874
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.7K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 临床试验 临床试验
  • 生物统计学 生物统计学

背景情况:

  • 慢性病 (CKD) 构成了全球健康负担,其进展到末期病 (ESKD) 导致死亡率增加.
  • 传统的脏复合终点在CKD试验中需要长时间的随访期.
  • 估计的淋巴细胞过率 (eGFR) 斜率是功能下降的有价值的替代终点,但缺乏标准化的估计方法.

研究的目的:

  • 为CKD随机对照试验 (RCT) 中基于eGFR斜率分析提出一个新的估计和框架.
  • 为了提高定义估计的清晰度,并改善CKD试验中结果的可比性.
  • 在不同的场景下评估各种估计技术对eGFR斜率的性能.

主要方法:

  • 在CKD RCT中开发针对eGFR斜率量身定制的估计和框架.
  • 进行模拟研究以评估估计技术.
  • 将方法应用于现实世界CKD患者数据.

主要成果:

  • 拟议的框架为eGFR斜率估计提供了一个明确的定义.
  • 评估确定了合适的估计方法,特别是对于具有较低竞争事件率的场景.
  • 该研究强调了将估计方法与特定试验目标协调的重要性.

结论:

  • 在CKD试验中,标准化的估计和框架对于可靠和可解释的eGFR斜率分析至关重要.
  • 这项工作通过提高CKD试验结果的一致性来推进治疗开发.
  • 这些发现支持更好的临床决策管理慢性病.